Latest news
Loading news…
EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.
EUSA Pharma was acquired by Recordati in 2021 for $850M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
2
Monthly Visits
Available in Pro Contacts
84
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Hemel Hempstead, Hertford, United Kingdom
Acquisitions by EUSA Pharma
Loading columns…
0 of 0Show
Page 1 / 1
Key People at EUSA Pharma
President
Founder, President & CEO
CFO
CFO
CEO
84
professional contacts at EUSA Pharma
Contact execs at EUSA Pharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to EUSA Pharma
Loading news…
FAQs about EUSA Pharma
People who checked this page also checked these
Sectors EUSA Pharma invests & acquires in
Browse the full Acquirezy directory.